Bilal Husam Jasim

Dr. Bilal Husam Jasim

University of Technology- Iraq, Baghdad, Baghdād, Iraq
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2024 in Heliyon
Verified
Journal Article
Open access
Ahmed Mutanabbi AbdulaAhmed Mutanabbi Abdula
Ahmed Mutanabbi Abdula
GMGhosoun Lafta Mohsen
Ghosoun Lafta Mohsen
BJBilal Husam Jasim
Bilal Husam Jasim
MJMajid S. Jabir
Majid S. Jabir
ARAbduljabbar I.R. Rushdi
Abduljabbar I.R. Rushdi
Younis BaqiYounis Baqi
Younis Baqi
New 3-furan-1-thiophene-based chalcones were synthesized, characterized and pharmacologically evaluated as antibacterial and anticancer agents against two bacterial species; Gram-positive (Streptococcus pyogenes) and Gram-negative (Pseudomonas aeruginosa). All tested final compounds were active against the two bacterial species; S. pyogenes and P . aeruginosa. Especially compound AM4 showed large inhibition zone (27.13 and 23.30 mm), respectively. Using the DPPH assay, the new chalcones were evaluated for their free radical scavenging activity and found to reach up to 90 %, accomplished at a test concentration of 200 μg/mL. Furthermore, the chalcone derivatives were investigated against two breast cell lines; MCF-7 (cancerous) and MCF-10A (non-cancerous). Compound AM4 showed potent anticancer activity (IC50 = 19.354 μg/mL) in comparison to the other tested chalcone derivatives. In silico study was achieved using the PyRx AutoDock Vina software (0.8) to study the interaction types between the new hits and the binding sites of targeted proteins; glucosamine-6-phosphate synthase and tubulin, the target for antibacterial and anticancer drugs, respectively. Based on the molecular docking results the tested chalcones bind to the active pocket of the respective proteins, which support the in vitro results. In conclusion, 3-furan-1-thiophene-based chalcones could serve as new hits in the discovery of novel anticancer and/or antibacterial drugs.


3 June 2024 in Journal of Applied Sciences and Nanotechnology
Verified
Journal Article
Open access
PDF file
MKMaryam Dhary Kamel
Maryam Dhary Kamel
AIAli A. Issa
Ali A. Issa
RSRand J. Sattar
Rand J. Sattar
RSRusul H. Sami
Rusul H. Sami
YHYasser A. Hussein
Yasser A. Hussein
BJBilal Husam Jasim
Bilal Husam Jasim
This study characterized the physicochemical properties and predicted the structure, function, and protein-protein interactions of bone morphogenetic protein 15 (BMP15) using bioinformatics tools. BMP15 was found to have a molecular weight of 45055.01 Daltons, sequence length of 392 amino acids, and an extinction coefficient of 55390 at 280 nm with a basic isoelectric point. Secondary structure analysis revealed BMP15 consists mostly of random coil (63.78%), followed by alpha helix (20.66%) and extended strand (15.56%) as well as beta turns. Amino acids with high coil structure like glycine and alanine, which are hydrophobic and flexible, represented the highest concentrations. Transmembrane helix prediction identified four helices located from inside to outside and three from outside to inside. SWISS-MODEL generated four protein structure models corresponding to sequences (Q6PX77.1. A, 5vqf.2. A, 5ntu.1. A, and 5hly.1. A) with sequence identities of (75.38%, 20.83%, 20.77% and 20.33%) respectively. Results correlate BMP15 with oocyte maturation and granulosa cell activation in follicular development. This comprehensive bioinformatics analysis of BMP15 properties, structure, and interactions provides a framework for further study of genetically inherited infertility, drug design, and new protein analysis.

1 July 2021 in Journal of Applied Sciences and Nanotechnology
Verified
Journal Article
Open access
PDF file
BJBilal Husam Jasim
Bilal Husam Jasim
EAEntesar Ali
Entesar Ali
Fibrinolytic enzyme is factor that lysis fibrin clots. This fibrinolytic factor has prospective use to treat cardiovascular diseases, such as stroke and heart attack. Cardiovascular diseases attracted worldwide attention for their elevation morbidity and mortality. Expensive cost and fatally undesired side effects associated with the available fibrinolytic agents to treat these diseases stimulated the researchers to investigate potentially better agents for curative applications. In the current investigation, fibrinolytic enzyme production from Pseudomonas aeruginosa isolated from injuries of wounds and burns patients. Parameters for the promoted production of the enzyme under minimal production media were optimized. It comprised carbon source (glucose), Nitrogen source (Yeast extract), Fibrinogen concentration (0.5 %), inoculum size (1 %), temperature (37°C), and PH (7). Enhanced fibrinolytic enzyme activity (136.2 IU/ml) was obtained after optimization Medium Components compared with that obtained with the minimal medium (60.2 IU/ml) which is 2.2 times higher than the same under non optimized production conditions. Media optimization researches for enhancement of fibrinolytic enzyme production from Pseudomonas aeruginosa in Iraq has not been performed so far. This may be the first study to optimization media for the production of fibrinolytic enzyme from Pseudomonas aeruginosa. The importance of this study lies in the enhancing the production of the fibrinolytic enzyme with high activity using these bacteria.

29 March 2025 in Indonesian Journal of Biotechnology
Verified
Journal Article
Open access
PDF file
BJBilal Husam Jasim
Bilal Husam Jasim
RSRand Jabbar Sattar
Rand Jabbar Sattar
MKMaryam Dhary Kamel
Maryam Dhary Kamel
EAEntesar Hussein Ali
Entesar Hussein Ali
MJMajid Sakhi Jabir
Majid Sakhi Jabir
ZFZahraa Abbas Fadhil
Zahraa Abbas Fadhil
Staphylokinase is a virulence factor produced by Staphylococcus aureus that enhances its ability to degrade proteins, contributing to tissue damage and increased bacterial invasiveness. This investigation studied staphylokinase production by S. aureus isolates obtained from wound and burn patients. Optimal conditions for enhancing staphylokinase production in Sato’s component were determined. These conditions included a carbon source (glucose), a nitrogen source (yeast extract), an inoculum size of 1%, an incubation temperature of 37 °C, and a pH of 7. Optimization of the medium components resulted in a significant increase in staphylokinase production (26.4 U/mL), representing a 2.23‐fold rise compared to production in the unoptimized Sato’s component. The crude staphylokinase enzyme exhibited thrombolytic activity against human blood clots, achieving 42% clot lysis. However, the crude enzyme showed no antibacterial activity against the tested bacteria (Streptomyces and Escherichia coli). This study represents the first report of optimized media for enhancing staphylokinase production from S. aureus. The research is significant because it establishes a method for improving the production of highly active staphylokinase from S. aureus, which has potential applications as a thrombolytic agent.

30 September 2024 in International Journal of Health & Medical Research
Verified
Journal Article
Closed access
NANawar Bahaa Abdulsahib
Nawar Bahaa Abdulsahib
YHYasser Ali Hussein
Yasser Ali Hussein
BJBilal Husam Jasim
Bilal Husam Jasim
Concern for antibiotic resistance in Gram negative bacteria is fast becoming a global issue due to the reduction of effectiveness of current drugs. This review deconstructs the material in a logical, categorized manner, examining the biochemistry of antibiotic resistance mechanisms such as efflux pumps, enzymatic degradation, genetic changes, and the regulation of those changes. Close associated gene transfer, especially the plasmids-mediated resistance, and how biofilms contribute to the survival of bacteria under antibiotic pressure. Present methods of detection and diagnosis are also described with emphasis on the importance of identifying a resistant strain quickly and accurately. Last, we discuss directions for ongoing and future progress in tackling antibiotic resistance, such as new treatments and public health directions. Based on these observations, it is the hope of this review to contribute to the existing literature and initiatives geared towards reversing the escalating problem of antibiotic resistance.